OBSOLETE: Lymphomatous meningitis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

2 events
Apr 2025Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma

Juan P. Alderuccio, MD — PHASE1

TrialRECRUITING
Apr 2025Methotrexate or Thiotepa Combined With R-CHOP and Orelabrutinib in CNSL Patients

Ruijin Hospital — PHASE2

TrialNOT YET RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

DepoCyt

Pacira Pharmaceuticals, Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

DepoCyt

(Cytarabine liposomal)Orphan drugstandard

Pacira Pharmaceuticals, Inc.

View full treatment details on disease page →

Clinical Trial Landscape

1 active trial
1Phase 1
1Total recruiting
Search clinical trials for OBSOLETE: Lymphomatous meningitis

Recent News & Research

No recent news articles indexed yet for OBSOLETE: Lymphomatous meningitis.
Search PubMed for OBSOLETE: Lymphomatous meningitis

Browse all OBSOLETE: Lymphomatous meningitis news →

Specialist Network

No specialists currently listed for OBSOLETE: Lymphomatous meningitis.

View all OBSOLETE: Lymphomatous meningitis specialists →

Quick Actions